SBDM 006
Alternative Names: SBDM-006Latest Information Update: 02 Jan 2023
At a glance
- Originator Shilpa Biologicals
- Class Anti-ischaemics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Myocardial infarction
Most Recent Events
- 05 Dec 2022 Early research in Myocardial infarction in India (Parenteral) (Shilpa Biologicals pipeline, December 2022)